促销时间表 Indivior PLC
先进的时间表
简单图表
关于公司
Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders. The company's product pipeline focuses on treating opioid use disorder, addiction, and schizophrenia. It markets and promotes SUBLOCADE injection for subcutaneous use; and SUBOXONE sublingual film, SUBOXONE sublingual tablet, and SUBUTEX sublingual tablet. The company operates in approximately 40 countries worldwide. It has collaboration agreement with Addex Therapeutics Ltd. 更多详情Цена ао | 8.71 |
---|---|
Выручка | 0.785 |
EBITDA | 0.23 |
Число акций ао | 0.13653 млрд |
P/E | 0.5628 |
P/S | 0.0961 |
P/BV | 0.3608 |
ISIN | GB00BN4HT335 |
Сайт | https://www.indivior.com |
Див.доход ао | 12.24 |
Дивиденд ао | 0.475 |
Валюта | usd |
IPO date | 2014-12-29 |
Sector | Health Care |
Industry | Biotechnology |
Валюта отчета | usd |
EV/EBITDA | -2.95 |
每日价格变化: | +0.1149% (8.7) |
---|---|
每周价格变化: | +10.25% (7.9) |
每月价格变化: | -8.12% (9.48) |
3个月内价格变化: | -19.94% (10.88) |
六个月内的价格变化: | -49.86% (17.37) |
每年价格变化: | -57.3% (20.4) |
3年内价格变化: | +1 309.39% (0.618) |
5年内价格变化: | +6 683.49% (0.1284) |
年初以来价格变化: | -48.21% (16.819) |
|
低估
|
效率
|
|||||||||||||||||||||||||||||||||||||
股息
|
责任
|
成长冲动
|
机构 | 体积 | 分享, % |
---|---|---|
Two Seas Capital LP | 13670312 | 9.96 |
Scopia Capital Management LP | 8311367 | 6.06 |
Vanguard Group Inc | 5846354 | 4.26 |
Goldman Sachs Group Inc | 5683038 | 4.14 |
FMR, LLC | 5498087 | 4.01 |
Artemis Investment Management LLP | 3127399 | 2.28 |
Bank of America Corporation | 2701855 | 1.97 |
Polar Capital Holdings PLC | 2621150 | 1.91 |
Acadian Asset Management. LLC | 2281179 | 1.66 |
Liontrust Investment Partners LLP | 1995889 | 1.45 |
导师 | 职称 | 支付 | 出生年份 |
---|---|---|---|
Mr. Mark Crossley | CEO & Executive Director | 2.34M | |
Mr. Ryan Preblick | CFO & Executive Director | 1.14M | |
Dr. Christian Heidbreder | Chief Scientific Officer | N/A | |
Mr. Jason Thompson | Vice President of Investor Relations | N/A | |
Ms. Cynthia Cetani | Chief Integrity & Compliance Officer | N/A | |
Mr. Jeffrey W. Burris | Chief Legal Officer | N/A | 1972 (52 年) |
Mr. Jon Fogle | Chief Human Resources Officer | N/A | |
Mr. Richard Simkin | Chief Commercial Officer | N/A | |
Mr. Hillel West | Chief Manufacturing & Supply Officer | N/A | |
Mr. Vishal Kalia | SVP of US Treatment Access, Support Programs & Business Insights and Chief Impact & Strategy Officer | N/A |
地址: United States, North Chesterfield. VA, 10710 Midlothian Turnpike - 在 Google 地图中打开, 打开 Yandex 地图
网站: https://www.indivior.com
网站: https://www.indivior.com